Skip to main content
. Author manuscript; available in PMC: 2021 Mar 12.
Published in final edited form as: Cancer Chemother Pharmacol. 2020 Oct 23;86(6):815–827. doi: 10.1007/s00280-020-04176-z

Fig. 2.

Fig. 2

Clinical response in a patient with Sertoli–Leydig tumor harboring AKT3 amplification and STK11 R304W mutation. Computed axial tomography (CT) coronal images are shown, yellow circles highlight the index mesenteric mass; baseline (left panel), following two cycles (middle panel), following six cycles (right panel)